Clinical Trials Browser

Phase 1/2 × Completed × epratuzumab × Clear all

NCT00421395 2021-08-16

Safety Study of NHL With 90Y-hLL2 IgG

Phase 1/2 Completed

Lymphoma, Non-Hodgkin

NCT00098839 2017-12-12

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Phase 1/2 Completed

134 enrolled 13 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma